Heidi Hagen
CIK 1585084 · Interim CEO · last filed 2026-05-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.31M
Companies
3
Total Filings
23
Lifetime Open-Market Net
-$890.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VCEL | Director | 35,050 | $37.46 | $1.31M | -$931.9K | 18 | 2026-05-01 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Interim CEO | 145,889 | $0.87 | $126.3K | $41.8K | 4 | 2021-09-03 |
| Vericel Corp (ASTM) Delisted | Director | — | — | — | $0 | 1 | 2013-08-27 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-06 | VCEL | Grant (A) | — | $0 | EDGAR |
| 2015-03-24 | VCEL | Grant (A) | — | $0 | EDGAR |
| 2013-08-27 | Vericel Corp (ASTM) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.